Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_assertion type Assertion NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_head.
- NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_assertion description "[Delineation of the adverse prognostic power of MDR1 in adult acute myeloid leukemia (AML) raised hopes that pharmacologic blockade of P-gp would improve the outcome of conventional cytotoxic therapy, perhaps more so than in any other human malignancy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_provenance.
- NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_assertion evidence source_evidence_literature NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_provenance.
- NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_assertion SIO_000772 15217827 NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_provenance.
- NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_assertion wasDerivedFrom befree-20150227 NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_provenance.
- NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_assertion wasGeneratedBy ECO_0000203 NP618505.RASAY77X7yN1f-8wUYyLG5JTQBNqJLvWhIl-FEK-qEEgA130_provenance.